152 related articles for article (PubMed ID: 8763850)
1. Chemical properties which control selectivity and efficacy of aromatic N-oxide bioreductive drugs.
Wardman P; Priyadarsini KI; Dennis MF; Everett SA; Naylor MA; Patel KB; Stratford IJ; Stratford MR; Tracy M
Br J Cancer Suppl; 1996 Jul; 27():S70-4. PubMed ID: 8763850
[TBL] [Abstract][Full Text] [Related]
2. Oxidation of 2-deoxyribose by benzotriazinyl radicals of antitumor 3-amino-1,2,4-benzotriazine 1,4-dioxides.
Shinde SS; Anderson RF; Hay MP; Gamage SA; Denny WA
J Am Chem Soc; 2004 Jun; 126(25):7865-74. PubMed ID: 15212534
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of the cytotoxicity of the anticancer agent tirapazamine by benzotriazine N-oxides: the role of redox equilibria.
Anderson RF; Shinde SS; Hay MP; Denny WA
J Am Chem Soc; 2006 Jan; 128(1):245-9. PubMed ID: 16390153
[TBL] [Abstract][Full Text] [Related]
4. Activation of 3-amino-1,2,4-benzotriazine 1,4-dioxide antitumor agents to oxidizing species following their one-electron reduction.
Anderson RF; Shinde SS; Hay MP; Gamage SA; Denny WA
J Am Chem Soc; 2003 Jan; 125(3):748-56. PubMed ID: 12526674
[TBL] [Abstract][Full Text] [Related]
5. Reaction of the hypoxia-selective antitumor agent tirapazamine with a C1'-radical in single-stranded and double-stranded DNA: the drug and its metabolites can serve as surrogates for molecular oxygen in radical-mediated DNA damage reactions.
Hwang JT; Greenberg MM; Fuchs T; Gates KS
Biochemistry; 1999 Oct; 38(43):14248-55. PubMed ID: 10571998
[TBL] [Abstract][Full Text] [Related]
6. Radical properties governing the hypoxia-selective cytotoxicity of antitumor 3-amino-1,2,4-benzotriazine 1,4-dioxides.
Anderson RF; Shinde SS; Hay MP; Gamage SA; Denny WA
Org Biomol Chem; 2005 Jun; 3(11):2167-74. PubMed ID: 15917906
[TBL] [Abstract][Full Text] [Related]
7. The one-electron reduction potential of 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine): a hypoxia-selective bioreductive drug.
Priyadarsini KI; Tracy M; Wardman P
Free Radic Res; 1996 Nov; 25(5):393-9. PubMed ID: 8902537
[TBL] [Abstract][Full Text] [Related]
8. Pulse radiolysis of the DNA-binding bisbenzimidazole derivatives Hoechst 33258 and 33342 in aqueous solutions.
Adhikary A; Bothe E; Jain V; Von Sonntag C
Int J Radiat Biol; 2000 Sep; 76(9):1157-66. PubMed ID: 10993627
[TBL] [Abstract][Full Text] [Related]
9. Electrochemical studies of tirapazamine: generation of the one-electron reduction product.
Tocher JH; Edwards DI
Free Radic Res; 1994 Oct; 21(5):277-83. PubMed ID: 7842137
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-selective agents derived from quinoxaline 1,4-di-N-oxides.
Monge A; Palop JA; López de Ceráin A; Senador V; Martínez-Crespo FJ; Sainz Y; Narro S; García E; de Miguel C; González M
J Med Chem; 1995 May; 38(10):1786-92. PubMed ID: 7752202
[TBL] [Abstract][Full Text] [Related]
11. Fragmentation of the quinoxaline N-oxide bond to the ˙OH radical upon one-electron bioreduction.
Yadav P; Marshall AJ; Reynisson J; Denny WA; Hay MP; Anderson RF
Chem Commun (Camb); 2014 Nov; 50(89):13729-31. PubMed ID: 25248989
[TBL] [Abstract][Full Text] [Related]
12. Characterization of radicals formed following enzymatic reduction of 3-substituted analogues of the hypoxia-selective cytotoxin 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine).
Shinde SS; Maroz A; Hay MP; Patterson AV; Denny WA; Anderson RF
J Am Chem Soc; 2010 Mar; 132(8):2591-9. PubMed ID: 20141134
[TBL] [Abstract][Full Text] [Related]
13. A mass spectrometry study of tirapazamine and its metabolites. insights into the mechanism of metabolic transformations and the characterization of reaction intermediates.
Zagorevskii D; Song M; Breneman C; Yuan Y; Fuchs T; Gates KS; Greenlief CM
J Am Soc Mass Spectrom; 2003 Aug; 14(8):881-92. PubMed ID: 12892912
[TBL] [Abstract][Full Text] [Related]
14. Electron paramagnetic resonance spectrometry evidence for bioreduction of tirapazamine to oxidising free radicals under anaerobic conditions.
Patterson LH; Taiwo FA
Biochem Pharmacol; 2000 Dec; 60(12):1933-5. PubMed ID: 11108810
[TBL] [Abstract][Full Text] [Related]
15. Electrochemical properties as a function of pH for the benzotriazine di-N-oxides.
Tocher JH; Virk NS; Edwards DI
Free Radic Res Commun; 1990; 10(4-5):295-302. PubMed ID: 2289695
[TBL] [Abstract][Full Text] [Related]
16. Spin Trapping Hydroxyl and Aryl Radicals of One-Electron Reduced Anticancer Benzotriazine 1,4-Dioxides.
Qi W; Yadav P; Hong CR; Stevenson RJ; Hay MP; Anderson RF
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164077
[TBL] [Abstract][Full Text] [Related]
17. Toward hypoxia-selective DNA-alkylating agents built by grafting nitrogen mustards onto the bioreductively activated, hypoxia-selective DNA-oxidizing agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine).
Johnson KM; Parsons ZD; Barnes CL; Gates KS
J Org Chem; 2014 Aug; 79(16):7520-31. PubMed ID: 25029663
[TBL] [Abstract][Full Text] [Related]
18. Electron transfer reactions in RB90745, a bioreductive drug having both aromatic N-oxide and nitroarene moieties.
Priyadarsini KI; Naylor MA; Stratford MR; Wardman P
Free Radic Res; 1996 Aug; 25(2):99-107. PubMed ID: 8885327
[TBL] [Abstract][Full Text] [Related]
19. Photochemical and photobiological studies of tirapazamine (SR 4233) and related quinoxaline 1,4-Di-N-oxide analogues.
Inbaraj JJ; Motten AG; Chignell CF
Chem Res Toxicol; 2003 Feb; 16(2):164-70. PubMed ID: 12588187
[TBL] [Abstract][Full Text] [Related]
20. Enhanced conversion of DNA radical damage to double strand breaks by 1,2,4-benzotriazine 1,4-dioxides linked to a DNA binder compared to tirapazamine.
Anderson RF; Harris TA; Hay MP; Denny WA
Chem Res Toxicol; 2003 Nov; 16(11):1477-83. PubMed ID: 14615975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
